Healthtech
Thyrocare sells Nueclear Healthcare stake for Rs 141 crore to exit radiology

PharmEasy-owned Thyrocare Technologies approved the sale of its entire stake in subsidiary Nueclear Healthcare for Rs 141 crore, exiting radiology. Builders: large diagnostic networks are narrowing focus. If you're in radiology tech, expect consolidation and margin compression—focus on operational efficiency, not expansion.
Source: Inc42 ↗
🎧 Arjun & Meera on this story — from 6:38 in the 22 September 2026 episode